The Lawrence C. Fuller, Jr., Memorial Diabetic Fund provides grant funding to support organizations that conduct research into the causes of diabetes and hypoglycemia and develop educational programs focused on their treatment, management, and prevention. The Fund’s mission is to improve public understanding and foster advancements in medical knowledge through both scientific research and public education.
The Fund prioritizes organizations located in Pennsylvania, though it does not impose formal geographic limitations. Funding is limited to organizations that are tax-exempt under Section 501(c)(3) of the Internal Revenue Code. Eligible activities include scientific research into the causes of diabetes and hypoglycemia and public education initiatives that address disease causes, treatment options, and effective disease management strategies.
The application cycle is open year-round, but in order to be considered at the annual grant review meeting, applications must be submitted by May 30. The grant committee meets in July, and award notifications typically follow shortly after. Applications must be submitted online through the fund’s digital portal.
The Fund generally awards three grants per year, with average grant amounts ranging from $10,000 to $15,000. Following funding, recipients are required to submit a progress report within six months of receiving funds unless other conditions are specified at the time of the award. Applicants receive an automated email confirmation upon successful submission of their application.
The Fund is managed by Wells Fargo Bank, N.A., acting as trustee, ensuring continuity, fiduciary oversight, and alignment with the fund’s objectives.
